A comprehensive view of Inflammations. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Scientists propose biodegradable, electrospun polyester nonwovens as wound healing dressings; nonwovens release propolis from honeybees, which has antioxidant, antibacterial, antifungal, anticancer, anti-inflammatory, analgesic, regenerative properties
Published: May 25, 2022 by Molecules
Regeneron and Sanofi receive approval in US for injectable anti-inflammatory drug Dupixent dupilumab to treat eosinophilic esophagitis in patients 12 years and older; it is the only approved drug in US specifically indicated to treat condition
Published: May 24, 2022 by SeeNews Pharmaceuticals
Gilead and Dragonfly Therapeutics announce strategic research collaboration to develop natural killer cell engagers for oncology, inflammation; Gilead makes US$300.0M payment to Dragonfly for rights to investigational immunotherapy program DF7001
Published: May 04, 2022 by Business Wire
AbbVie’s Rinvoq upadacitinib oral drug has been approved in US to treat inflammatory spine disease active ankylosing spondylitis; drug previously approved to treat other inflammatory diseases, with AbbVie expecting sales of over US$7.5B by 2025
Published: May 04, 2022 by SeeNews Pharmaceuticals
AbbVie announces FDA approval of RINVOQ tablets for treatment of adults with moderately to severely active ulcerative colitis
Published: March 16, 2022 by PR Newswire

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count